Here are three things to know:
1. Following clean (class I, not contaminated) surgical procedures, the SSI rate should be less than about 2 percent. However, an infection rate of 12.2 percent has been reported after removing orthopedic implants used for treatment of fractures below the knee.
2. This randomized clinical trial included 470 patients undergoing surgery for removal of implants for below-the-knee fractures. A single preoperative intravenous dose of 1000 milligrams of cefazolin or sodium chloride were administered to 228 or 242 patients, respectively.
3. A single preoperative dose of intravenous cefazolin compared with saline did not reduce the risk of SSI within 30 days following implant removal.
More articles on quality:
Study: Outpatient shoulder surgery in ASCs safe for patients 65+ years
How leading antimicrobial stewardship programs combat antibiotic resistance — 3 key takeaways
Cookeville Center for Pain Management owner to pay $1.45M for prescribing “useless” painkillers
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
